ORCID: https://orcid.org/0000-0002-5990-494X; Li, Li; Bruchfeld, Annette; Stevens, Kate I.; Moran, Sarah M.; Floege, Jürgen; Caravaca-Fontán, Fernando
ORCID: https://orcid.org/0000-0002-5830-9663; Mirioglu, Safak
ORCID: https://orcid.org/0000-0003-0362-8154; Teng, Onno Y.K.
ORCID: https://orcid.org/0000-0001-9920-2195; Frangou, Eleni und Kronbichler, Andreas
ORCID: https://orcid.org/0000-0002-2945-2946
(2025):
Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication.
In: Kidney International, Bd. 107, Nr. 1: S. 51-67
[PDF, 2MB]

Abstract
Sex is a key variable in the regulation of human physiology and pathology. Many diseases disproportionately affect one sex: autoimmune diseases, such as systemic lupus erythematosus, are more common in women but more severe in men, whereas the incidence of other disorders such as gouty arthritis and malignant cancers is higher in men. Besides the pathophysiology, sex may also influence the efficacy of therapeutics; participants in clinical trials are still predominately men, and the side effects of drugs are more common in women than in men. Sex dimorphism is a prominent feature of kidney physiology and function, and consequently affects the predisposition to many adult kidney diseases. These differences subsequently influence the response to immune stimuli, hormones, and therapies. It is highly likely that these responses differ between the sexes. Therefore, it becomes imperative to consider sex differences in translational science from basic science to preclinical research to clinical research and trials. Under-representation of one sex in preclinical animal studies or clinical trials remains an issue and key reported outcomes of such studies ought to be presented separately. Without this, it remains difficult to tailor the management of kidney disease appropriately and effectively. In this review, we provide mechanistic insights into sex differences in rodents and humans, both in kidney health and disease, highlight the importance of considering sex differences in the design of any preclinical animal or clinical study, and propose guidance on how to optimal design and conduct preclinical animal studies in future research.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin > Klinikum der LMU München > Medizinische Klinik und Poliklinik IV (Endokrinologie, Nephrologie, weitere Sektionen) |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-125462-5 |
ISSN: | 00852538 |
Sprache: | Englisch |
Dokumenten ID: | 125462 |
Datum der Veröffentlichung auf Open Access LMU: | 16. Mai 2025 11:38 |
Letzte Änderungen: | 16. Mai 2025 11:38 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 466036526 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 449437943 |